Helius Medical Technologies, Inc. Stock Toronto S.E.
Equities
HSM
US42328V1089
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% |
|
+4.21% | -.--% |
Sales 2024 * | 703K 958K | Sales 2025 * | 1.31M 1.78M | Capitalization | 2.5M 3.4M |
---|---|---|---|---|---|
Net income 2024 * | -10M -13.63M | Net income 2025 * | -14M -19.08M | EV / Sales 2024 * | 3.55 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.91 x |
P/E ratio 2024 * |
-0.15
x | P/E ratio 2025 * |
-0.28
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.22% |
Latest transcript on Helius Medical Technologies, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Dane Andreeff
CEO | Chief Executive Officer | 58 | 17-08-03 |
Director of Finance/CFO | 62 | 20-06-08 | |
Chief Tech/Sci/R&D Officer | 57 | 21-07-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Straw
BRD | Director/Board Member | 85 | 14-11-17 |
Dane Andreeff
CEO | Chief Executive Officer | 58 | 17-08-03 |
Blane Walter
CHM | Chairman | 53 | 15-12-28 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.26% | 209B | |
+6.55% | 183B | |
+31.66% | 158B | |
+34.32% | 114B | |
+5.13% | 67.29B | |
+19.33% | 54.83B | |
-3.30% | 46.88B | |
-4.84% | 38.58B | |
+3.83% | 36.65B |
- Stock Market
- Equities
- HSDT Stock
- HSM Stock